European equity markets weakened in October following multiple disappointments across the earnings season. The impending US election, the outcome of which is highly uncertain according to the polls, may also have prompted some traders to adopt a cautious stance. Sovereign long rates rose sharply, particularly in the US, on the back of macro indicators likely to provide arguments to the most hawkish of central bankers. All eyes are now on the November 5 elections and their repercussion...
Les marchés actions européens ont fléchi en octobre après les nombreuses déceptions sur la saison des résultats. L’approche de l’élection US, très incertaine selon les sondages, pourrait également avoir poussé à la prudence certains opérateurs. Les taux longs souverains ont nettement remonté, en particulier aux Etats-Unis, sur la base d’indicateurs macro susceptibles de donner des arguments aux plus faucons des banquiers centraux. Tous les yeux sont désormais rivés sur le scrutin du 5...
>Outperform rating maintained – target price raised to € 0.56 (vs € 0.48) - The Q3/9M 2024 results, and more importantly the medium-term strategic update, support our positive call on BCP against the backdrop of 1/ a significant recovery in operations/profitability; and 2/ a notable improvement in shareholder returns (thanks to increasingly comfortable solvency) in the short and medium term. Despite the share’s significant rerating (+64% YTD, +38pp vs sector), we stil...
>Opinion Surperformance maintenue. OC porté à 0.56 € (vs 0.48 €) - Les résultats T3/9M 2024 et surtout l’update stratégique MT confortent notre call positif sur BCP sur fond 1/ de redressement significatif de l’opérationnel/rentabilité et 2/ d’amélioration notable du retour à l’actionnaire (grâce à une solvabilité de plus en plus confortable) à CMT. Malgré le rerating significatif du titre (+64% YTD, +38 pp vs secteur) nous identifions encore du potentiel de revaloris...
A director at Banco Comercial Portugues bought 68,970 shares at 0.390EUR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
The Stoxx 600 gained just 1.1% in July after shedding 1.3% in June, driven by the SMI (+2.5%) and the Footsie 100 (+2.7%). With business sentiment indicators continuing to weaken, defensive stocks outperformed cyclicals in July, and many healthcare stocks were among the best performers of the Stoxx 600. Long-term interest rates have fallen sharply (probably too much), but this has not benefited tech and luxury goods stocks, penalised by their disappointing results publications. - ...
Le Stoxx 600 ne progresse que de 1,1% en juillet après sa baisse de 1,3% en juin, tiré par le SMI (+2,5%) et le Footsie 100 (+2,7%). Avec la poursuite du fléchissement des indicateurs de climat des affaires, les défensives ont surperformé les cycliques en juillet, et de nombreuses valeurs Santé sont présentes parmi les meilleures performances du Stoxx 600. Les taux d’intérêt longs ont nettement reflué (sans doute trop) sans que cela profite aux valeurs de la Tech ou du Luxe qui ont s...
>Outperform rating confirmed. Target price raised to € 0.48 (vs € 0.47) - BCP’s Q2/H1 2024 results support our positive stance on the group, with confirmation of the prospect of a significant recovery in underlying operating momentum/profitability in the short to medium term and a substantial strengthening of its solvency (with the possibility of a sizeable improvement in shareholder returns as well). Despite the stock’s strong performance since April (+42% YTD, +20p ...
>Opinion Surperformance confortée. OC porté à 0.48 € (vs 0.47 €) - Les résultats T2/S1 2024 confortent notre call positif sur BCP avec la validation des perspectives de redressement significatif de l’opérationnel underlying/rentabilité à CMT et de renforcement notable de la solvabilité (avec en toile de fond l’idée d’une amélioration notable également du retour à l’actionnaire). Malgré la jolie performance boursière du titre depuis avril (+42% YTD, +20 pp vs secteur),...
>Outperform rating maintained – target price raised to € 0.47 (vs € 0.43) - BCP’s Q1 2024 results lend weight to our positive call on the bank, which is based on a significant recovery in its underlying operating momentum and profitability in the short to medium term, coupled with sizeable solvency strengthening (and the related prospect of a solid improvement in shareholder returns). Despite the upturn in the re-rating since April (+28% YTD, +2 pp vs the sector) and ...
>Opinion Surperformance maintenue – OC porté à 0.47 € (vs 0.43 €) - Les résultats T1 2024 confortent notre call positif sur BCP, axé pour rappel sur le redressement significatif de l’opérationnel underlying et de la rentabilité à CMT couplé au renforcement notable de la solvabilité (et in fine la perspective associée d’amélioration notable du retour à l’actionnaire). En dépit de la reprise notable du processus de rerating du titre depuis avril (+28% YTD, +2 pp vs sect...
With the exception of the US, construction markets should continue to shrink in 2024 (-2% in Europe) before rebounding on the back of lower interest rates. Against this backdrop, groups will be differentiated mainly on the basis of their resilience (geographical and price/cost mix), capital allocation (and special situations) and valuation. In this context, we are upgrading our recommendations on KONE (modernisation as an alternative source of growth to China) and Holcim (a substantia...
Hormis les Etats-Unis, les marchés de la construction devraient continuer à reculer en 2024 (-2% en Europe) avant de rebondir à la faveur d’une baisse des taux. Dans ce contexte, la différenciation entre les groupes se fera essentiellement sur leur capacité de résistance (mix géographique et prix/ coûts), l’allocation du capital (et situations spéciales) et leur valorisation. Face à cet environnement, nous relevons nos recommandations sur KONE (la modernisation comme relais de la Chin...
>Outperform rating confirmed – target price raised to € 0.43 (vs € 0.41) - The Q4/full-year 2023 results confirmed our fundamentally positive approach on BCP, which as a reminder is based on a significant recovery on the underlying operating and profitability fronts in the short to medium term, as well as a notably strengthening of solvency (and ultimately the related prospect of a notable improvement in shareholder returns). The relative pause in the share re-rating ...
>Opinion Surperformance confortée – OC porté à 0.43 € (vs 0.41 €) - Les résultats T4/annuels 2023 sont venus conforter notre approche fondamentalement positive sur BCP, reposant pour rappel sur le redressement significatif de l’opérationnel underlying et de la rentabilité à CMT ainsi que le renforcement notable de la solvabilité (et in fine la perspective associée d’amélioration notable du retour à l’actionnaire). La relative pause observée depuis notre dernier point ...
Banks tick all the boxes in the market’s current configuration: search for discounted sectors, cyclical momentum, sectors driven by long-term interest rates that remain high and shareholder returns through very high dividend yields. Technical analysis reveals a strong conviction since early March, and this should continue. We prefer banks in southern Europe, where the macro outlook is brighter. Alongside CaixaBank, which we are maintaining in our list of European Large Cap stocks, we ...
Banks tick all the boxes in the market’s current configuration: search for discounted sectors, cyclical momentum, sectors driven by long-term interest rates that remain high and shareholder returns through very high dividend yields. Technical analysis reveals a strong conviction since early March, and this should continue. We prefer banks in southern Europe, where the macro outlook is brighter. Alongside CaixaBank, which we are maintaining in our list of European Large Cap stocks, we ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.